Table 2.

Cost-effectiveness of incobotulinumtoxin-A compared to conventional therapy and scenarios with different discount rates and time horizon.

Discount rate/ Horizon time	Costs (Euro)			QALYs			ICER (Euro/ QALY)
	INCO	CON	Incremental	INCO	CON	Incremental
Combined scenarios
3%/3years	3605.26	2524.56	1080.70	29.71	28.55	1.17	926
5%/3 years	5746.37	4085.21	1661.16	48.13	46.28	1.85	898
3%/5years	3508.89	2458.91	1049.97	28.89	27.76	1.13	927
5%/5 years	5492.80	3906.03	1586.77	45.95	44.18	1.77	899